Phase I-2020: Done
WP1. Synthesis and characterization of new magnetic theranostic nanosystems.
Phase II-2021: Done
WP2. In vitro evaluation of magnetic theranostic nanosystems.
Phase III-2022: Done
WP3. In vivo evaluation of magnetic theranostic nanosystems.